{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:57:16Z","timestamp":1784044636731,"version":"3.55.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:00:00Z","timestamp":1767139200000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Influenza virus infection remains a major cause of morbidity in allogeneic hematopoietic stem cell transplant (allo-HCT) recipients. Vaccination is a key preventive strategy; yet, clinical evidence of its benefit in this population is limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective, multicenter observational study including adult allo-HCT recipients (\u226516 years) who developed laboratory-confirmed influenza infection between 2013 and 2023, with the aim of assessing the impact of vaccination on influenza disease severity. Vaccinated status was defined as having received the seasonal influenza vaccine during the same season and before the onset of influenza infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 143 recipients with 214 influenza episodes were analyzed. The median age was 45 years (range 18\u201370), and 58% had acute leukemia or myeloid malignancies. Most (64.3%) received transplants from unrelated or haploidentical family donors. Overall, 48 episodes (22%) occurred after influenza vaccination. At infection onset, 52% of vaccinated recipients were profoundly immunosuppressed (within &amp;lt;6 months post-transplant, experiencing active graft-versus-host disease, or receiving immunosuppressors or corticosteroids). Progression to lower respiratory tract disease (LRTD) occurred in 29% of episodes. Multivariable analysis showed influenza vaccination was significantly associated with reduced LRTD risk (HR 0.18; 95% CI: 0.06\u20130.50; P = .001), while a high-risk immunodeficiency scoring index (ISI) (HR 4.71; 95% CI: 1.99\u201311.17; P = .0004) and fever at screening (HR 2.16; 95% CI: 1.51\u20133.08; P &amp;lt; .001) independently predicted higher LRTD risk. Vaccination was also associated with decreased hospitalization risk (OR 0.20; 95% CI: 0.05\u20130.57; P = .005); whereas, high-risk ISI was linked to higher admission risk (OR 22.86; 95% CI: 4.82\u2013170, P = .0003).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study provides real-world evidence that seasonal influenza vaccination may reduce disease severity in allo-HCT recipients and confirms the prognostic value of the ISI for disease risk assessment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ofid\/ofaf800","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T12:46:22Z","timestamp":1767185182000},"source":"Crossref","is-referenced-by-count":1,"title":["Vaccination as a Key Determinant of Influenza Disease Severity in Allogeneic Hematopoietic Stem Cell Transplant Recipients: An Observational Retrospective Study"],"prefix":"10.1093","volume":"13","author":[{"given":"Clara Isabel","family":"Mart\u00ednez-L\u00f3pez","sequence":"first","affiliation":[{"name":"Department of Hematology, Hospital Cl\u00ednico Universitario de Valencia, INCLIVA Biomedical Research Institute , Valencia ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6741-971X","authenticated-orcid":false,"given":"Pedro","family":"Chor\u00e3o","sequence":"additional","affiliation":[{"name":"Hematology Division, Hospital Universitario y Polit\u00e9cnico La Fe , Valencia ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariadna","family":"P\u00e9rez","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hospital Cl\u00ednico Universitario de Valencia, INCLIVA Biomedical Research Institute , Valencia ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brais","family":"Lamas","sequence":"additional","affiliation":[{"name":"Hematology Division, Hospital Universitario y Polit\u00e9cnico La Fe , Valencia ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6960-078X","authenticated-orcid":false,"given":"Dolores","family":"G\u00f3mez","sequence":"additional","affiliation":[{"name":"Microbiology Service, Hospital Universitario y Polit\u00e9cnico La Fe , Valencia ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Solano de la Asunci\u00f3n","sequence":"additional","affiliation":[{"name":"Microbiology Service, Hospital Cl\u00ednico Universitario , Valencia ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Sanz","sequence":"additional","affiliation":[{"name":"Hematology Division, Hospital Universitario y Polit\u00e9cnico La Fe , Valencia ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Hern\u00e1ndez-Boluda","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hospital Cl\u00ednico Universitario de Valencia, INCLIVA Biomedical Research Institute , Valencia ,","place":["Spain"]},{"name":"Department of Medicine, School of Medicine, University of Valencia , Valencia ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Navarro","sequence":"additional","affiliation":[{"name":"Microbiology Service, Hospital Cl\u00ednico Universitario , Valencia ,","place":["Spain"]},{"name":"Department of Microbiology, School of Medicine, University of Valencia , Valencia ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Montoro","sequence":"additional","affiliation":[{"name":"Hematology Division, Hospital Universitario y Polit\u00e9cnico La Fe , Valencia ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Solano","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hospital Cl\u00ednico Universitario de Valencia, INCLIVA Biomedical Research Institute , Valencia ,","place":["Spain"]},{"name":"Department of Medicine, School of Medicine, University of Valencia , Valencia ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8533-2562","authenticated-orcid":false,"given":"Jos\u00e9 Luis","family":"Pi\u00f1ana","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hospital Cl\u00ednico Universitario de Valencia, INCLIVA Biomedical Research Institute , Valencia ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,12,31]]},"reference":[{"key":"2026010906565001900_ofaf800-B1","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.bbmt.2005.07.007","article-title":"Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies","volume":"11","author":"Martino","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"2026010906565001900_ofaf800-B2","doi-asserted-by":"crossref","first-page":"e14117","DOI":"10.1111\/tid.14117","article-title":"Infectious complications subcommittee of the Spanish hematopoietic stem cell transplantation and cell therapy group (GETH-TC). respiratory virus infections after allogeneic stem cell transplantation: current understanding, knowledge gaps, and recent advances","volume":"25","author":"Pi\u00f1ana","year":"2023","journal-title":"Transpl Infect Dis"},{"key":"2026010906565001900_ofaf800-B3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/978-1-4939-9034-4_11","article-title":"Infections in allogeneic stem cell transplantation","author":"Pereira","year":"2018","journal-title":"Principles Pract Transpl Infect Dis"},{"key":"2026010906565001900_ofaf800-B4","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.jiac.2022.05.014","article-title":"Risk factors for lower respiratory tract disease and outcomes in allogeneic hematopoietic stem cell transplantation recipients with influenza virus infection","volume":"28","author":"Shiraiwa","year":"2022","journal-title":"J Infect Chemother"},{"key":"2026010906565001900_ofaf800-B5","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.3324\/haematol.2011.041913","article-title":"Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients","volume":"96","author":"Ljungman","year":"2011","journal-title":"Haematologica"},{"key":"2026010906565001900_ofaf800-B6","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1159\/000320789","article-title":"Pandemic 2009 H1N1 influenza in patients with hematopoietic stem cell transplantation and hematologic malignancy: single center experience","volume":"79","author":"Tekg\u00fcnd\u00fcz","year":"2011","journal-title":"Oncology"},{"key":"2026010906565001900_ofaf800-B7","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.3389\/fmicb.2018.03294","article-title":"Respiratory virus infections in hematopoietic cell transplant recipients","volume":"9","author":"Pochon","year":"2018","journal-title":"Front Microbiol"},{"key":"2026010906565001900_ofaf800-B8","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/978-3-031-44080-9_38","volume-title":"The EBMT handbook: hematopoietic cell transplantation and cellular therapies","author":"Ljungman","year":"2024","edition":"8th ed"},{"key":"2026010906565001900_ofaf800-B9","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1016\/S1473-3099(18)30600-5","article-title":"Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7)","volume":"19","author":"Cordonnier","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2026010906565001900_ofaf800-B10","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1093\/cid\/cit684","article-title":"2013 IDSA clinical practice guideline for vaccination of the immunocompromised host","volume":"58","author":"Rubin","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2026010906565001900_ofaf800-B11"},{"key":"2026010906565001900_ofaf800-B12","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1200\/JCO.24.00032","article-title":"Vaccination of adults with cancer: ASCO guideline","volume":"42","author":"Kamboj","year":"2024","journal-title":"J Clin Oncol"},{"key":"2026010906565001900_ofaf800-B13","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1093\/cid\/ciy792","article-title":"Clinical effectiveness of influenza vaccination after allogeneic hematopoietic stem cell transplantation: a cross-sectional, prospective, observational study","volume":"68","author":"Pi\u00f1ana","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2026010906565001900_ofaf800-B14","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/sj.bmt.1705159","article-title":"The benefit of influenza vaccination after bone marrow transplantation","volume":"36","author":"Machado","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"2026010906565001900_ofaf800-B15","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1093\/infdis\/jiab391","article-title":"Association of host factors with antibody response to seasonal influenza vaccination in allogeneic hematopoietic stem cell transplant patients","volume":"225","author":"Linnik","year":"2022","journal-title":"J Infect Dis"},{"key":"2026010906565001900_ofaf800-B16","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/TP.0b013e3181772a75","article-title":"Evaluation of immune responses to seasonal influenza vaccination in healthy volunteers and in patients after stem cell transplantation","volume":"86","author":"Avetisyan","year":"2008","journal-title":"Transplantation"},{"key":"2026010906565001900_ofaf800-B17","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s41409-019-0698-7","article-title":"The effect of timing on community acquired respiratory virus infection mortality during the first year after allogeneic hematopoietic stem cell transplantation: a prospective epidemiological survey","volume":"55","author":"Pi\u00f1ana","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"2026010906565001900_ofaf800-B18","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1182\/blood-2013-12-541359","article-title":"Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infections","volume":"123","author":"Shah","year":"2014","journal-title":"Blood"},{"key":"2026010906565001900_ofaf800-B19","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1093\/cid\/ciu134","article-title":"Parainfluenza virus lower respiratory tract disease after hematopoietic cell transplant: viral detection in the lung predicts outcome","volume":"58","author":"Seo","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2026010906565001900_ofaf800-B20","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/cid\/cis844","article-title":"Fourth European conference on infections in leukaemia (ECIL-4): guidelines for diagnosis and treatment of human respiratory syncytial virus, parainfluenza virus, metapneumovirus, rhinovirus, and coronavirus","volume":"56","author":"Hirsch","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2026010906565001900_ofaf800-B21","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1086\/425004","article-title":"Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy","volume":"39","author":"Nichols","year":"2004","journal-title":"Clin Infect Dis"},{"key":"2026010906565001900_ofaf800-B22","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41409-022-01575-z","article-title":"Novel factors to predict respiratory viral disease progression in allogeneic hematopoietic cell transplant recipients","volume":"57","author":"Ogimi","year":"2022","journal-title":"Bone Marrow Transplant"},{"key":"2026010906565001900_ofaf800-B23","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1093\/cid\/ciae602","article-title":"Community-acquired respiratory virus infections: a threat to long-term survivors after allogeneic stem cell transplant?","volume":"81","author":"Pi\u00f1ana","year":"2025","journal-title":"Clin Infect Dis"},{"key":"2026010906565001900_ofaf800-B24"},{"key":"2026010906565001900_ofaf800-B25","doi-asserted-by":"crossref","first-page":"6140","DOI":"10.3390\/cancers13236140","article-title":"Vaccine responses in adult hematopoietic stem cell transplant recipients: a comprehensive review","volume":"13","author":"Janssen","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2026010906565001900_ofaf800-B26","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/cid\/ciad534","article-title":"The durability of antibody responses of two doses of high-dose relative to two doses of standard-dose inactivated influenza vaccine in pediatric hematopoietic cell transplant recipients: a multi-center randomized controlled trial","volume":"78","author":"Schuster","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2026010906565001900_ofaf800-B27","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bbmt.2012.08.015","article-title":"A randomized trial of one versus two doses of influenza vaccine after allogeneic transplantation","volume":"19","author":"Karras","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"2026010906565001900_ofaf800-B28","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/cid\/ciad458","article-title":"Comparison of two high-dose versus two standard-dose influenza vaccines in adult allogeneic hematopoietic cell transplant recipients","volume":"77","author":"Thomas","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2026010906565001900_ofaf800-B29","doi-asserted-by":"crossref","first-page":"896","DOI":"10.3324\/haematol.2011.040386","article-title":"Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A\/09\/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients","volume":"96","author":"Mohty","year":"2011","journal-title":"Haematologica"},{"key":"2026010906565001900_ofaf800-B30","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/sj.bmt.1705964","article-title":"Invasive pneumococcal disease in adult hematopoietic stem cell transplant recipients: a decade of prospective population-based surveillance","volume":"41","author":"Kumar","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"2026010906565001900_ofaf800-B31","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/tid.12110","article-title":"Vaccination adherence in hematopoietic stem cell transplant patients: a pilot study on the impact of vaccination cards and reminder telephone calls","volume":"15","author":"Lerchenfeldt","year":"2013","journal-title":"Transpl Infect Dis"},{"key":"2026010906565001900_ofaf800-B32","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/tid.12312","article-title":"Vaccination guidelines after hematopoietic stem cell transplantation: practitioners\u2019 knowledge, attitudes, and gap between guidelines and clinical practice","volume":"16","author":"Ariza-Heredia","year":"2014","journal-title":"Transpl Infect Dis"},{"key":"2026010906565001900_ofaf800-B33","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jtct.2025.02.019","article-title":"T cell immune response to influenza vaccination when administered prior to and following autologous chimeric antigen receptor-modified T cell therapy","volume":"31","author":"Kinoshita","year":"2025","journal-title":"Transplant Cell Ther"},{"key":"2026010906565001900_ofaf800-B34","doi-asserted-by":"crossref","first-page":"6333","DOI":"10.4049\/jimmunol.176.10.6333","article-title":"T cell responses are better correlates of vaccine protection in the elderly","volume":"176","author":"McElhaney","year":"2006","journal-title":"J Immunol"},{"key":"2026010906565001900_ofaf800-B35","doi-asserted-by":"crossref","first-page":"e0047224","DOI":"10.1128\/iai.00472-24","article-title":"Infection-induced trained immunity: a twist in paradigm of innate host defense and generation of immunological memory","volume":"93","author":"Bahl","year":"2025","journal-title":"Infect Immun"},{"key":"2026010906565001900_ofaf800-B36","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.bbmt.2015.11.015","article-title":"Outcomes of influenza infections in hematopoietic cell transplant recipients: application of an immunodeficiency scoring Index","volume":"22","author":"Kmeid","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"2026010906565001900_ofaf800-B37","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1111\/j.1600-6143.2008.02374.x","article-title":"Female-versus-male alloreactivity as a model for minor histocompatibility antigens in hematopoietic stem cell transplantation","volume":"8","author":"Stern","year":"2008","journal-title":"Am J Transplant"},{"key":"2026010906565001900_ofaf800-B38","doi-asserted-by":"crossref","first-page":"526","DOI":"10.3324\/haematol.2012.065599","article-title":"The combination of sirolimus plus tacrolimus improves outcome after reduced-intensity conditioning, unrelated donor hematopoietic stem cell transplantation compared with cyclosporine plus mycophenolate","volume":"98","author":"Perez-Sim\u00f3n","year":"2013","journal-title":"Haematologica"},{"key":"2026010906565001900_ofaf800-B39","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/msc.1603","article-title":"The systemic immunosuppressive effects of peripheral corticosteroid injections: a narrative review of the evidence in the context of COVID-19","volume":"20","author":"Regan","year":"2022","journal-title":"Musculoskeletal Care"},{"key":"2026010906565001900_ofaf800-B40","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1038\/s41409-020-0921-6","article-title":"Uniform graft-versus-host disease prophylaxis with posttransplant cyclophosphamide, sirolimus, and mycophenolate mofetil following hematopoietic stem cell transplantation from haploidentical, matched sibling and unrelated donors","volume":"55","author":"Montoro","year":"2020","journal-title":"Bone Marrow Transplant"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofaf800\/66183499\/ofaf800.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/1\/ofaf800\/66183499\/ofaf800.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/1\/ofaf800\/66183499\/ofaf800.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T11:57:04Z","timestamp":1767959824000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofaf800\/8407828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,26]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12,26]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofaf800","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2025,12,26]]},"article-number":"ofaf800"}}